Drugs.com - Pharma Industry News

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery

WEDNESDAY, March 12, 2025 -- Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery.Vasundhara Mathur, M.D., from...

Mar 12, 2025 - 18:25
 0
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
WEDNESDAY, March 12, 2025 -- Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery.Vasundhara Mathur, M.D., from...
Read More

Tags:

Previous Article

Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk

Next Article

ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer

Related Posts

Opioid Rx in the ED Slightly Raises Risk for Future Opioid Use, Hospitalization

Opioid Rx in the ED Slightly Raises Risk for Future Opi...

Feb 10, 2025  0

Improvements in Prostate Cancer Mortality Plateaued From 2012 to 2021

Improvements in Prostate Cancer Mortality Plateaued Fro...

Feb 9, 2025  0

Study Reveals Link Between Forever Chemicals and Childhood Cancers

Study Reveals Link Between Forever Chemicals and Childh...

Mar 5, 2025  0